Tumor Ablation Market Size Worth $4.17 Billion by 2032 | CAGR: 11.3%

The global tumor ablation market size is expected to reach USD 4.17 billion by 2032, according to a new study by Polaris Market Research. The report “Tumor Ablation Market Share, Size, Trends, Industry Analysis Report, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others); By Mode of Treatment; By Application and; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Technical advancements, mainly in robotics-assisted tumor ablation techniques, are a significant driver in the tumor ablation market. Robotics systems, accomplished with navigation capabilities and advanced imaging, facilitate surgeons to diminish cancer tissues and accurately target with less damage to the healthy cells.

Microwave ablation (MWA) is the latest technology that eliminates tumors by utilizing heat which was generated by microwave energy. The surgeon inserts an open incision or tiny laparoscopic port to access the tumor by using the technology.

An ultrasonic guidance or CT scan is utilized to identify the exact location of the tumor in the body. A thin antenna, which radiates microwaves, is then injected into the tumor. The probe delivers intense heat that kills tumor tissue, predominantly within 10 minutes.

Key strategies executed by major players to bolster their product portfolios, such as collaborations and partnerships, are anticipated to have a positive impact on the tumor ablation market. Terumo Europe and University Medical Center Utrecht (UMC Utrecht), for instance, signed a Memorandum of Understanding (MoU) in July 2021 to enhance their persistent partnership in oncology, involving chemoembolization and tumor ablation through technological innovations.

The rising incidence of lung cancer, fueled by the expansion of unhealthy habits and a surge in research and development endeavors associated with product launches, is driving the growth of the market.

According to the 2023 statistics from the American Cancer Society, an evaluated 238,340 new cases of lung cancer are anticipated to be diagnosed in the US. Hence, the increased prevalence of lung cancer cases is anticipated to drive demand for tumor ablation devices, thereby contributing to market growth throughout the forecast period.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market/request-for-sample

The increasing priority for image-guided ablation techniques allows for specific targeting of tumors while minimizing damage to encircling healthy tissue. Also, there's a rising adoption of radiofrequency and microwave ablation technologies, delivering efficient and effective treatment options. The tumor ablation market is witnessing an increase in demand for minimally invasive techniques owing to their associated benefits, like shorter recovery times and reduced complications. Continuous research and development efforts are leading to innovations in ablation devices and techniques, contributing to the overall growth of the market.

Top of FormTumor Ablation Market Report Highlights

• In 2022, the radiofrequency ablation segment accounted for the largest revenue share in the tumor ablation market. The precision and safety of radiofrequency ablation, which have significantly improved with recent technological advancements, make it a significant choice for both physicians and patients. Additionally, its cost-effectiveness in comparison to traditional surgical approaches has contributed to its widespread adoption of tumor ablation.
• The lung cancer segment growing at the fastest as smoking is the leading cause of lung cancer, accounting for the majority of cases.
• In 2022, North America accounted for the largest market share in the tumor ablation market. Several key elements, such as governmental support for robust healthcare, high purchasing power, accessible reimbursements, and rising incidences of cancer, fuel the growth of this region. In the US, the Patient Protection and Affordable Care Act (PPACA) acts as a standard, advocating for the enhancement of healthcare quality and affordability through comprehensive health coverage policies. This, in turn, reduces healthcare costs for individuals and the government.
• The Asia-Pacific region accounted for the fastest growth in the market. The rising aging population has numerous chronic illnesses, including cancer and diabetes. Moreover, the expanding market with a surge in companies and substantial investments by major manufacturers in research and development for products are projected to contribute to the growth of the tumor ablation market in the region.
• The global key market players include AngioDynamics Inc., Boston Scientific Corp., BVM Medical Ltd., BTG International Ltd., EDAP TMS S.A., Integra LifeSciences Holdings Corp., Medtronic plc., Mermaid Medical, SonaCare Medical LLC, St. Jude Medical Inc.

Polaris Market Research has segmented the tumor ablation market report based on technology, mode of treatment, application, and region:

Tumor Ablation, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

• Radiofrequency (RF) Ablation
• Microwave Ablation
• Cryoablation
• Others

Tumor Ablation, Mode of Treatment Outlook (Revenue - USD Billion, 2019 - 2032)

• Surgical Ablation
• Laparoscopic Ablation
• Percutaneous Ablation

Tumor Ablation, Application Outlook (Revenue - USD Billion, 2019 - 2032)

• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Bone Metastasis
• Others      

Tumor Ablation, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of Asia Pacific

• Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa

Tumor ablation Report Scope: